January 16, 2021

The Niche

Trusted stem cell blog & resources

ACT stock

1 min read

Here is a link to the Ocata website, marking the start of a new era for what was formerly Advanced Cell Technology or ACT. It’s been a big summer for stem cell biotech Advanced Cell Technology (ACT; stock ACTCD) as it continues what I would call a process of reinventing itself. What’s been happening? ACT recently did a notable 100:1 reverse split on its stock, opening it up to a whole new group of investors. The company has also settled some previously lingering litigation and …Read More